2023
DOI: 10.1002/ardp.202200610
|View full text |Cite
|
Sign up to set email alerts
|

Development of a multigram synthesis of the bradykinin receptor 2 agonist FR‐190997 and analogs thereof

Abstract: Using Fujisawa's B2R agonist FR-190997, we recently demonstrated for the first time that agonism at the bradykinin receptor type 2 (B2R) produces substantial antiproliferative effects. FR-190997 elicited an EC 50 of 80 nM in the triple-negative breast cancer cell line MDA-MB-231, a much superior performance to that exhibited by most approved breast cancer drugs. Consequently, we initiated a program aiming primarily at synthesizing adequate quantities of FR-190997 to support further in vitro and in vivo studies… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…Initially, we tested the conditions we had previously employed in the classical Heck reaction of ethyl acrylate with aryl bromides using Pd(OAc) 2 / t Bu 3 P (3 and 6 mol % respectively) and Et 3 N in DMF [26a] . This however, including variations in the solvent and base, led to a complex mixture of products.…”
Section: Resultsmentioning
confidence: 99%
“…Initially, we tested the conditions we had previously employed in the classical Heck reaction of ethyl acrylate with aryl bromides using Pd(OAc) 2 / t Bu 3 P (3 and 6 mol % respectively) and Et 3 N in DMF [26a] . This however, including variations in the solvent and base, led to a complex mixture of products.…”
Section: Resultsmentioning
confidence: 99%